Postoperative lenvatinib + PD-1 blockade reduces early tumor recurrence in hepatocellular carcinoma with microvascular invasion (Barcelona Clinic Liver Cancer stage 0 or A): a propensity score matching analysis.
Awang DanzengLing GuoZhen-Hua YangZheng-Wei HeCheng-Long ZengPingcuo CirenRun-Hu LanXue-Wei JiangChao WangBin-Hao ZhangPublished in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2024)
Postoperative lenvatinib + PD-1 blockade improved the RFS in patients with HCC with MVI and was particularly beneficial for specific individuals.